Breaking News Instant updates and real-time market news.

RIGL

Rigel Pharmaceuticals

$3.57

-0.15 (-4.03%)

20:21
12/14/17
12/14
20:21
12/14/17
20:21

Rigel Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald

Cantor initiated Rigel Pharmaceuticals with an Overweight and $6 price target.

  • 14

    Dec

  • 17

    Apr

RIGL Rigel Pharmaceuticals
$3.57

-0.15 (-4.03%)

06/20/17
BMOC
06/20/17
NO CHANGE
BMOC
Rigel Pharmaceuticals price target raised to $5 from $4 at BMO Capital
BMO Capital analyst Do Kim increased the price target on Rigel after the FDA accepted the company's NDA filing for its Tavalisse drug in chronic ITP. As a result of the news, the analyst raised the estimate of the chances of the drug being successful to 80% from 70%. Kim expects an FDA panel to issue a positive recommendation on the drug at the end of this year or the beginning of 2018 and recommends that investors buy the stock before such a panel is announced. Kim says that the panel could be announced in the fall. Kim raised the price target on the shares to $5 from 44 and keeps an Outperform rating.
10/03/17
JEFF
10/03/17
NO CHANGE
JEFF
Rigel reported 'encouraging news' for second straight day, says Jefferies
Jefferies analyst Eun Yang says this morning's positive preliminary Phase 2 data for fostamatinib in hemolytic anemia marks the second day in a row of "encouraging news" from Rigel Pharmaceuticals. This is an additional indication as fostamatinib is currently under FDA review for the immune thrombocytopenic purpura indication, Yang tells investors in a research note. If both indications are approved, Yang sees a fair value for Rigel shares of $9-$10. The analyst keeps a Buy rating on the stock with a $5 price target. Rigel in early trading is down 21c to $3.16.
11/06/17
HCWC
11/06/17
INITIATION
Target $7
HCWC
Buy
Rigel Pharmaceuticals assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis assumed coverage of Rigel Pharmaceuticals with a Buy rating and $7 price target. The analyst projects FDA approval of fostamatinib for the treatment of immune thrombocytopenic purpura by the April 2018 action date. He also believes that a "significant upcoming potential driver" could be the signing of a major outside the U.S. partnership for the drug.
11/06/17
11/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CarGurus (CARG) was initiated with a Sector Perform at RBC Capital, a Market Perform at Raymond James and JMP Securities, and a Neutral at Goldman Sachs. 2. OrthoPediatrics (KIDS) was initiated with a Buy at Stifel and BTIG while being initiated with an Overweight at Piper Jaffray. 3. Rimini Street (RMNI) initiated with an Outperform at Cowen. 4. Rigel Pharmaceuticals (RIGL) assumed with a Buy at H.C. Wainwright. 5. Great Elm Capital (GECC) initiated with a Neutral at Janney Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

WEX

Wex

$194.01

-2 (-1.02%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Initiation
Wex initiated  »

Wex initiated with a Peer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$231.01

4.71 (2.08%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Periodicals
Lloyd Blankfein writes farewell memo to Goldman Sachs team, NY Times reports »

Goldman Sachs CEO LLoyd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$58.79

1.04 (1.80%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Recommendations
Nevro analyst commentary  »

Nevro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

FLT

FleetCor

$216.11

-4.06 (-1.84%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FleetCor initiated  »

FleetCor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$66.95

-0.06 (-0.09%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 15

    Aug

  • 16

    Aug

FIS

FIS

$107.72

-0.45 (-0.42%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FIS initiated  »

FIS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

09:35
07/17/18
07/17
09:35
07/17/18
09:35
General news
Treasury Action: yields traded mixed-to-lower with stocks »

Treasury Action: yields…

EPAM

Epam Systems

$132.28

-1.3 (-0.97%)

09:34
07/17/18
07/17
09:34
07/17/18
09:34
Initiation
Epam Systems initiated  »

Epam Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 15

    Aug

  • 16

    Aug

PAYX

Paychex

$69.99

-0.57 (-0.81%)

09:34
07/17/18
07/17
09:34
07/17/18
09:34
Initiation
Paychex initiated  »

Paychex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

09:34
07/17/18
07/17
09:34
07/17/18
09:34
Initiation
Fiserv initiated  »

Fiserv initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CLGX

CoreLogic

$53.31

0.04 (0.08%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
CoreLogic initiated  »

CoreLogic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ADS

Alliance Data

$218.91

-24.58 (-10.09%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
Alliance Data initiated  »

Alliance Data initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

WU

Western Union

$20.27

-0.09 (-0.44%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
Western Union initiated  »

Western Union initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$137.13

-0.19 (-0.14%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
ADP initiated  »

ADP initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

DXC

DXC Technology

$85.74

-0.41 (-0.48%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Initiation
DXC Technology initiated  »

DXC Technology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$167.63

-0.48 (-0.29%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Initiation
Accenture initiated  »

Accenture initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$63.96

-0.74 (-1.14%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Technical Analysis
Technical Earnings Preview: CSX may have double-topped before news »

On the 1-year, daily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

GPN

Global Payments

$117.00

-0.98 (-0.83%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

TSS

TSYS

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
TSYS initiated  »

TSYS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

RARE

Ultragenyx

$84.32

-0.23 (-0.27%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Recommendations
Ultragenyx analyst commentary  »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

KTOS

Kratos Defense

$12.85

0.14 (1.10%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Hot Stocks
Kratos Defense receives $8.5M in orders in support of C5 programs »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$81.97

0.26 (0.32%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
Cognizant initiated  »

Cognizant initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 15

    Aug

  • 16

    Aug

LTC

LTC Properties

$41.84

-0.32 (-0.76%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Hot Stocks
LTC Properties acquires two communities for $25.2M »

LTC Properties announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WP

Worldpay

$86.51

(0.00%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
Worldpay initiated  »

Worldpay initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

FDC

First Data

$22.24

-0.06 (-0.27%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
First Data initiated  »

First Data initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.